1 1544 205 KUNDALINI YOGA MEDITATION VERSUS THE RELAXATION RESPONSE MEDITATION FOR TREATING ADULTS WITH OBSESSIVE-COMPULSIVE DISORDER: A RANDOMIZED CLINICAL TRIAL. BACKGROUND: OBSESSIVE-COMPULSIVE DISORDER (OCD) IS OFTEN A LIFE-LONG DISORDER WITH HIGH PSYCHOSOCIAL IMPAIRMENT. SEROTONIN REUPTAKE INHIBITORS (SRIS) ARE THE ONLY FDA APPROVED DRUGS, AND APPROXIMATELY 50% OF PATIENTS ARE NON-RESPONDERS WHEN USING A CRITERION OF 25% TO 35% IMPROVEMENT WITH THE YALE-BROWN OBSESSIVE-COMPULSIVE SCALE (Y-BOCS). ABOUT 30% ARE NON-RESPONDERS TO COMBINED FIRST-LINE THERAPIES (SRIS AND EXPOSURE AND RESPONSE PREVENTION). PREVIOUS RESEARCH (ONE OPEN, ONE RANDOMIZED CLINICAL TRIAL) HAS DEMONSTRATED THAT KUNDALINI YOGA (KY) MEDITATION CAN LEAD TO AN IMPROVEMENT IN SYMPTOMS OF OBSESSIVE-COMPULSIVE SEVERITY. WE EXPAND HERE WITH A LARGER TRIAL. DESIGN: THIS TRIAL COMPARED TWO PARALLEL RUN GROUPS [KY VS. RELAXATION RESPONSE MEDITATION (RR)]. PATIENTS WERE RANDOMLY ALLOCATED BASED ON GENDER AND Y-BOCS SCORES. THEY WERE TOLD TWO DIFFERENT (UNNAMED) TYPES OF MEDITATION WOULD BE COMPARED, AND INFORMED IF ONE SHOWED GREATER BENEFITS, THE GROUPS WOULD MERGE FOR 12 MONTHS USING THE MORE EFFECTIVE INTERVENTION. RATERS WERE BLIND IN PHASE ONE (0-4.5 MONTHS) TO PATIENT ASSIGNMENTS, BUT NOT IN PHASE TWO. MAIN OUTCOME MEASURES: PRIMARY OUTCOME VARIABLE, CLINICIAN-ADMINISTERED Y-BOCS. SECONDARY SCALES: DIMENSIONAL YALE-BROWN OBSESSIVE COMPULSIVE SCALE (CLINICIAN-ADMINISTERED), PROFILE OF MOOD SCALES, BECK ANXIETY INVENTORY, BECK DEPRESSION INVENTORY, CLINICAL GLOBAL IMPRESSION, SHORT FORM 36 HEALTH SURVEY. RESULTS: PHASE ONE: BASELINE Y-BOCS SCORES: KY MEAN = 26.46 (SD 5.124; N = 24), RR MEAN = 26.79 (SD = 4.578; N = 24). AN INTENT-TO-TREAT ANALYSIS WITH THE LAST OBSERVATION CARRIED FORWARD FOR DROPOUTS SHOWED STATISTICALLY GREATER IMPROVEMENT WITH KY COMPARED TO RR ON THE Y-BOCS, AND STATISTICALLY GREATER IMPROVEMENT ON FIVE OF SIX SECONDARY MEASURES. FOR COMPLETERS, THE Y-BOCS SHOWED 40.4% IMPROVEMENT FOR KY (N = 16), 17.9% FOR RR (N = 11); 31.3% IN KY WERE JUDGED TO BE IN REMISSION COMPARED TO 9.1% IN RR. KY COMPLETERS SHOWED GREATER IMPROVEMENT ON FIVE OF SIX SECONDARY MEASURES. AT THE END OF PHASE TWO (12 MONTHS), PATIENTS, DRAWN FROM THE INITIAL GROUPS, WHO ELECTED TO RECEIVE KY CONTINUED TO SHOW IMPROVEMENT IN THEIR Y-BOCS SCORES. CONCLUSION: KY SHOWS PROMISE AS AN ADD-ON OPTION FOR OCD PATIENTS UNRESPONSIVE TO FIRST LINE THERAPIES. FUTURE STUDIES WILL ESTABLISH KY'S RELATIVE EFFICACY COMPARED TO EXPOSURE AND RESPONSE PREVENTION AND/OR MEDICATIONS, AND THE MOST EFFECTIVE TREATMENT SCHEDULE. CLINICAL TRIAL REGISTRATION: WWW.CLINICALTRIALS.GOV, IDENTIFIER NCT01833442. 2019 2 915 50 EFFECTIVENESS OF RAJYOGA MEDITATION AS AN ADJUNCT TO FIRST-LINE TREATMENT IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER. BACKGROUND: YOGA IS A SET OF MENTAL, PHYSICAL, AND SPIRITUAL PRACTICES WITH ITS ORIGIN IN ANCIENT INDIA. THE RENEWED INTEREST IN YOGA HAS LED TO THE EXPLORATION OF ITS BENEFITS IN A VARIETY OF PSYCHIATRIC DISORDERS SUCH AS SCHIZOPHRENIA, DEPRESSION, AND ANXIETY DISORDERS. THERE IS A DEARTH OF LITERATURE ON THE EFFECT OF YOGA IN OBSESSIVE COMPULSIVE DISORDER (OCD) IN THE INDIAN CONTEXT. AIM: THE PRESENT STUDY WAS CONDUCTED TO FIND OUT THE EFFICACY OF RAJYOGA MEDITATION (RM) AS AN ADJUNCT TO THE FIRST-LINE TREATMENT IN THE TREATMENT OF OCD. MATERIALS AND METHODS: PATIENTS WITH OCD (DIAGNOSED ACCORDING TO DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS FIFTH EDITION) WERE DIVIDED INTO TWO GROUPS - (I) THE MEDITATION GROUP (MG), WHICH INCLUDED 28 PATIENTS AND (II) THE NONMEDITATIVE GROUP (NMG), WHICH INCLUDED 22 PATIENTS. MG PRACTICED RM PROTOCOL FOR 3 MONTHS DURATION IN ADDITION TO THE PHARMACOLOGICAL TREATMENT. THE NMG CONTINUED ON PHARMACOLOGICAL MANAGEMENT AS USUAL. THE SYMPTOMATOLOGY WAS ASSESSED AT BASELINE AND 3 MONTHS USING THE YALE-BROWN OBSESSIVE-COMPULSIVE SCALE (Y-BOCS). RESULTS: AT 3 MONTHS, BOTH GROUPS DEMONSTRATED IMPROVEMENT IN SYMPTOMS. THE IMPROVEMENT IN MG WAS STATISTICALLY SIGNIFICANT WITH A CHANGE OF 9.0 +/- 3.16 IN Y-BOCS AND A 49.76 +/- 9.52% REDUCTION IN SYMPTOMS. IMPROVEMENT SCORES OF NMG WERE ALSO STATISTICALLY SIGNIFICANT WITH A CHANGE OF 3.13 +/- 2.59 IN Y-BOCS AND 18.09 +/- 14.69% REDUCTION IN SYMPTOMS. MG SHOWED SIGNIFICANTLY MORE IMPROVEMENT IN Y-BOCS SCORES (49.76 +/- 9.52) AS COMPARED TO NMG (18.09 +/- 14.69) USING THE STUDENT'S PAIRED T-TEST (P < 0.001). CONCLUSION: THE PRESENT STUDY SUGGESTS THAT THE RM IS AN EFFECTIVE ADJUNCTIVE THERAPY TO REDUCE OBSESSIONS AND COMPULSIONS IN PATIENTS WITH OCD. 2020 3 2796 39 YOGA THERAPY FOR OBSESSIVE COMPULSIVE DISORDER (OCD): A CASE SERIES FROM INDIA. YOGA IS AN ANCIENT SCIENCE WHICH HAS BEEN FOUND TO BE HELPFUL IN THE MANAGEMENT OF SEVERAL PSYCHIATRIC DISORDERS INCLUDING OBSESSIVE COMPULSIVE DISORDER (OCD). YOGA AS ADD-ON TREATMENT IN OCD MAY HELP ADDRESS ISSUES LIKE PARTIAL RESPONSE AND ADVERSE EFFECTS OF MEDICATIONS. HOWEVER, RESEARCH IN THIS AREA IS SPARSE, WHICH LED US TO EXPLORE IT THROUGH THIS CASE SERIES. IN THIS CASE SERIES WE HAVE DESCRIBED THE BENEFITS OF 1 MONTH OF YOGA AS ADD-ON TREATMENT IN PATIENTS WITH OCD. ALL PATIENTS WERE ON STABLE DOSES OF MEDICATIONS PRIOR TO AND DURING YOGA PRACTICE. PRE-POST ASSESSMENTS FOR THE CORE SYMPTOMS OF OBSESSION/COMPULSIONS AS WELL AS DEPRESSIVE AND ANXIETY SYMPTOMS WERE DONE. THE ASSESSMENTS SHOWED SIGNIFICANT IMPROVEMENT IN Y-BOCS AND HAM-D SCORES AFTER 1 MONTH OF YOGA. YOGA THERAPY COULD BE AN EFFECTIVE ADD-ON THERAPY FOR THE TREATMENT OF OCD. 2021 4 246 33 A YOGA INTERVENTION FOR POSTTRAUMATIC STRESS: A PRELIMINARY RANDOMIZED CONTROL TRIAL. YOGA MAY BE EFFECTIVE IN THE REDUCTION OF PTSD SYMPTOMOLOGY. THE PURPOSE OF THIS STUDY WAS TO EVALUATE THE IMPACT OF A KUNDALINI YOGA (KY) TREATMENT ON PTSD SYMPTOMS AND OVERALL WELLBEING. TO SUPPLEMENT THE CURRENT FIELD OF INQUIRY, A PILOT RANDOMIZED CONTROL TRIAL (RCT) WAS CONDUCTED COMPARING AN 8-SESSION KY INTERVENTION WITH A WAITLIST CONTROL GROUP. 80 INDIVIDUALS WITH CURRENT PTSD SYMPTOMS PARTICIPATED. BOTH GROUPS DEMONSTRATED CHANGES IN PTSD SYMPTOMOLOGY BUT YOGA PARTICIPANTS SHOWED GREATER CHANGES IN MEASURES OF SLEEP, POSITIVE AFFECT, PERCEIVED STRESS, ANXIETY, STRESS, AND RESILIENCE. BETWEEN-GROUPS EFFECT SIZES WERE SMALL TO MODERATE (0.09-0.25). KY MAY BE AN ADJUNCTIVE OR ALTERNATIVE INTERVENTION FOR PTSD. FINDINGS INDICATE THE NEED FOR FURTHER YOGA RESEARCH TO BETTER UNDERSTAND THE MECHANISM OF YOGA IN RELATION TO MENTAL AND PHYSICAL HEALTH, GENDER AND ETHNIC COMPARISONS, AND SHORT- AND LONG-TERM YOGA PRACTICE FOR PSYCHIATRIC CONDITIONS. 2015 5 290 46 ADJUNCTIVE YOGA V. HEALTH EDUCATION FOR PERSISTENT MAJOR DEPRESSION: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: THE OBJECTIVE OF THIS STUDY WAS TO DETERMINE WHETHER HATHA YOGA IS AN EFFICACIOUS ADJUNCTIVE INTERVENTION FOR INDIVIDUALS WITH CONTINUED DEPRESSIVE SYMPTOMS DESPITE ANTIDEPRESSANT TREATMENT. METHOD: WE CONDUCTED A RANDOMIZED CONTROLLED TRIAL OF WEEKLY YOGA CLASSES (N = 63) V. HEALTH EDUCATION CLASSES (HEALTHY LIVING WORKSHOP; HLW; N = 59) IN INDIVIDUALS WITH ELEVATED DEPRESSION SYMPTOMS AND ANTIDEPRESSANT MEDICATION USE. HLW SERVED AS AN ATTENTION-CONTROL GROUP. THE INTERVENTION PERIOD WAS 10 WEEKS, WITH FOLLOW-UP ASSESSMENTS 3 AND 6 MONTHS AFTERWARDS. THE PRIMARY OUTCOME WAS DEPRESSION SYMPTOM SEVERITY ASSESSED BY BLIND RATER AT 10 WEEKS. SECONDARY OUTCOMES INCLUDED DEPRESSION SYMPTOMS OVER THE ENTIRE INTERVENTION AND FOLLOW-UP PERIODS, SOCIAL AND ROLE FUNCTIONING, GENERAL HEALTH PERCEPTIONS, PAIN, AND PHYSICAL FUNCTIONING. RESULTS: AT 10 WEEKS, WE DID NOT FIND A STATISTICALLY SIGNIFICANT DIFFERENCE BETWEEN GROUPS IN DEPRESSION SYMPTOMS (B = -0.82, S.E. = 0.88, P = 0.36). HOWEVER, OVER THE ENTIRE INTERVENTION AND FOLLOW-UP PERIOD, WHEN CONTROLLING FOR BASELINE, YOGA PARTICIPANTS SHOWED LOWER LEVELS OF DEPRESSION THAN HLW PARTICIPANTS (B = -1.38, S.E. = 0.57, P = 0.02). AT 6-MONTH FOLLOW-UP, 51% OF YOGA PARTICIPANTS DEMONSTRATED A RESPONSE (50% REDUCTION IN DEPRESSION SYMPTOMS) COMPARED WITH 31% OF HLW PARTICIPANTS (ODDS RATIO = 2.31; P = 0.04). YOGA PARTICIPANTS SHOWED SIGNIFICANTLY BETTER SOCIAL AND ROLE FUNCTIONING AND GENERAL HEALTH PERCEPTIONS OVER TIME. CONCLUSIONS: ALTHOUGH WE DID NOT SEE A DIFFERENCE IN DEPRESSION SYMPTOMS AT THE END OF THE INTERVENTION PERIOD, YOGA PARTICIPANTS SHOWED FEWER DEPRESSION SYMPTOMS OVER THE ENTIRE FOLLOW-UP PERIOD. BENEFITS OF YOGA MAY ACCUMULATE OVER TIME. 2017 6 1705 51 PATIENT PERSPECTIVES: KUNDALINI YOGA MEDITATION TECHNIQUES FOR PSYCHO-ONCOLOGY AND AS POTENTIAL THERAPIES FOR CANCER. THE ANCIENT SYSTEM OF KUNDALINI YOGA (KY) INCLUDES A VAST ARRAY OF MEDITATION TECHNIQUES. SOME WERE DISCOVERED TO BE SPECIFIC FOR TREATING PSYCHIATRIC DISORDERS AND OTHERS ARE SUPPOSEDLY BENEFICIAL FOR TREATING CANCERS. TO DATE, 2 CLINICAL TRIALS HAVE BEEN CONDUCTED FOR TREATING OBSESSIVE-COMPULSIVE DISORDER (OCD). THE FIRST WAS AN OPEN UNCONTROLLED TRIAL AND THE SECOND A SINGLE-BLINDED RANDOMIZED CONTROLLED TRIAL (RCT) COMPARING A KY PROTOCOL AGAINST THE RELAXATION RESPONSE AND MINDFULNESS MEDITATION (RRMM) TECHNIQUES COMBINED. BOTH TRIALS SHOWED EFFICACY ON ALL PSYCHOLOGICAL SCALES USING THE KY PROTOCOL; HOWEVER, THE RCT SHOWED NO EFFICACY ON ANY SCALE WITH THE RRMM CONTROL GROUP. THE KY PROTOCOL EMPLOYED AN OCD-SPECIFIC MEDITATION TECHNIQUE COMBINED WITH OTHER TECHNIQUES THAT ARE INDIVIDUALLY SPECIFIC FOR ANXIETY, LOW ENERGY, FEAR, ANGER, MEETING MENTAL CHALLENGES, AND TURNING NEGATIVE THOUGHTS INTO POSITIVE THOUGHTS. IN ADDITION TO OCD SYMPTOMS, OTHER SYMPTOMS, INCLUDING ANXIETY AND DEPRESSION, WERE ALSO SIGNIFICANTLY REDUCED. ELEMENTS OF THE KY PROTOCOL OTHER THAN THE OCD-SPECIFIC TECHNIQUE ALSO MAY HAVE APPLICATIONS FOR PSYCHO-ONCOLOGY PATIENTS AND ARE DESCRIBED HERE. TWO DEPRESSION-SPECIFIC KY TECHNIQUES ARE DESCRIBED THAT ALSO HELP COMBAT MENTAL FATIGUE AND LOW ENERGY. A 7-PART PROTOCOL IS DESCRIBED THAT WOULD BE USED IN KY PRACTICE TO AFFECT THE FULL SPECTRUM OF EMOTIONS AND DISTRESS THAT COMPLICATE A CANCER DIAGNOSIS. IN ADDITION, THERE ARE KY TECHNIQUES THAT PRACTITIONERS HAVE USED IN TREATING CANCER. THESE TECHNIQUES HAVE NOT YET BEEN SUBJECTED TO FORMAL CLINICAL TRIALS BUT ARE DESCRIBED HERE AS POTENTIAL ADJUNCTIVE THERAPIES. A CASE HISTORY DEMONSTRATING RAPID ONSET OF ACUTE RELIEF OF INTENSE FEAR IN A TERMINAL BREAST CANCER PATIENT USING A KY TECHNIQUE SPECIFIC FOR FEAR IS PRESENTED. A SECOND CASE HISTORY IS REPORTED FOR A SURVIVING MALE DIAGNOSED IN 1988 WITH TERMINAL PROSTATE CANCER WHO HAS USED KY THERAPY LONG TERM AS PART OF A SELF-DIRECTED INTEGRATIVE CARE APPROACH. 2005 7 657 32 EFFECT OF 'EXERCISE WITHOUT MOVEMENT' YOGA METHOD ON MINDFULNESS, ANXIETY AND DEPRESSION. OBJECTIVE: TO ANALYZE THE EFFECT OF THE 'EXERCISE WITHOUT MOVEMENT' (E.W.M) YOGA METHOD ON MINDFULNESS AND ON THE IMPROVEMENT OF ANXIETY AND DEPRESSION SYMPTOMS. METHODS: A QUASI-EXPERIMENTAL STUDY EXAMINED THE EFFECT OF ONE MONTH E.W.M. INTERVENTION AMONG 38 PARTICIPANTS WHO WERE ENROLLED VOLUNTARILY TO BOTH GROUPS, STUDY (N = 16) AND CONTROL (N = 22). FIVE PARTICIPANTS DROPPED OUT DURING THE STUDY. THE STATE MINDFULNESS SCALE (SMS) WAS USED TO MEASURE MINDFULNESS. THE ANXIETY INVENTORY BECK (BAI) AND THE BECK DEPRESSION INVENTORY (BDI-II) WERE USED TO MEASURE THE ANXIETY AND DEPRESSION SYMPTOMS, RESPECTIVELY, BEFORE AND AFTER THE INTERVENTION. RESULTS: STUDY GROUP SHOWED BOTH A STATISTICALLY SIGNIFICANT INCREASE IN MINDFULNESS AND DECREASE IN ANXIETY AND DEPRESSION SYMPTOMS, COMPARED WITH THE CONTROL GROUP. CONCLUSIONS: THE E.W.M. HAS BEEN USEFUL IN THE DEVELOPMENT OF MINDFULNESS AND IN THE TREATMENT OF ANXIETY AND DEPRESSION SYMPTOMS AND MAY REPRESENT A NEW METHOD IN THE MINDFULNESS-BASED THERAPEUTIC APPLICATION. 2016 8 1542 35 KRIYA YOGA IN PATIENTS WITH DEPRESSIVE DISORDERS: A PILOT STUDY. BACKGROUND AND OBJECTIVES DESPITE THE EASY ACCEPTABILITY AND HOLISTIC NATURE OF KRIYA YOGA, THERE ARE NO STUDIES EVALUATING THE ROLE OF KRIYA YOGA INTERVENTION ON DEPRESSION. THE OBJECTIVE OF THE CURRENT STUDY WAS TO ASSESS THE FEASIBILITY AND EFFECT OF ADJUNCTIVE KRIYA YOGA ON DEPRESSION. METHODS PATIENTS WITH MAJOR DEPRESSIVE DISORDER WHO OPTED FOR KRIYA YOGA WERE RECRUITED INTO THE INTERVENTION GROUP (ADJUNCTIVE KRIYA YOGA) AND THOSE ON PSYCHOTROPIC MEDICATION ALONE WERE ENROLLED INTO THE CONTROL GROUP. THE HAMILTON DEPRESSION RATING SCALE (HDRS) MEASUREMENTS WERE RECORDED AT BASELINE, END OF 2, 4, AND 8 WEEKS. RESULTS HDRS SCORES OF THE INTERVENTION GROUP ( N = 29) WERE FOUND TO BE SIGNIFICANTLY LESSER THAN THAT OF THE CONTROL GROUP ( N = 52) BY THE END OF 2, 4, AND 8 WEEKS. THE REMISSION RATE WAS ALSO SIGNIFICANTLY GREATER IN THE INTERVENTION GROUP. CONCLUSION KRIYA YOGA INTERVENTION WAS FOUND TO BE FEASIBLE, AS WELL AS IMPROVED THE SEVERITY OF DEPRESSION. 2021 9 1833 25 PSYCHOLOGICAL WELLNESS, YOGA AND QUALITY OF LIFE IN PATIENTS AFFECTED BY SCHIZOPHRENIA SPECTRUM DISORDERS: A PILOT STUDY. SCHIZOPHRENIA IS A SERIOUS PSYCHIATRIC DISORDER CHARACTERIZED BY POSITIVE SYMPTOMS, NEGATIVE SYMPTOMS AND NEUROCOGNITIVE DEFICITS. THE AIM OF THIS STUDY WAS TO ESTIMATE RELATIONSHIPS BETWEEN WELLNESS, YOGA AND QUALITY OF LIFE IN PATIENTS AFFECTED BY SCHIZOPHRENIA SPECTRUM DISORDERS. PARTICIPANTS WERE 30 PATIENTS WITH A DIAGNOSIS OF SCHIZOPHRENIA IN CARE AT THE REHABILITATIVE PSYCHIATRY AND RESEARCH VILLA CHIARA CLINIC IN MASCALUCIA (CATANIA, ITALY), AFTER THAT RANDOMLY ASSIGNED TO TWO GROUPS. THE FIRST GROUP FOLLOWED THE EXPERIMENTAL TREATMENT WITH SETS OF YOGA EXERCISES CONDUCTED BY A YOGA TRAINER AND A PSYCHIATRIST OR A CLINICAL PSYCHOLOGIST EXPERT IN YOGA, WHILE A SECOND CONTROL GROUP WAS TREATED WITH USUAL CARE. THE RESULTS REVEALED A SIGNIFICANT DIFFERENCE, BEFORE AND AFTER TREATMENT, BETWEEN THE EXPERIMENTAL GROUP AND THE CONTROL GROUP IN QUALITY OF LIFE. 2019 10 2653 42 YOGA IMPROVES OCCUPATIONAL PERFORMANCE, DEPRESSION, AND DAILY ACTIVITIES FOR PEOPLE WITH CHRONIC PAIN. BACKGROUND: CHRONIC PAIN IS A COMPLEX ACCUMULATION OF PHYSICAL, PSYCHOLOGICAL, AND SOCIAL CONDITIONS, THUS INTERVENTIONS THAT ADDRESS PAIN AND PROMOTE OCCUPATIONAL PERFORMANCE ARE NEEDED. A HOLISTIC INTERVENTION, WITH MIND AND BODY COMPONENTS, IS LIKELY NECESSARY TO BEST TREAT THE COMPLEXITIES OF CHRONIC PAIN. THUS, WE DEVELOPED AND TESTED A YOGA INTERVENTION FOR PEOPLE WITH CHRONIC PAIN. OBJECTIVES: IN A RANDOMIZED CONTROL TRIAL (RCT), PARTICIPANTS WITH CHRONIC PAIN WERE RANDOMIZED TO A YOGA INTERVENTION OR USUAL CARE GROUP. BETWEEN AND WITHIN GROUP DIFFERENCES FOR PRE-AND POST-OUTCOME MEASURE SCORES WERE ASSESSED FOR: OCCUPATIONAL PERFORMANCE, COMPLETION OF ACTIVITIES, AND DEPRESSION. METHODS: PILOT RCT WITH PARTICIPANT ALLOCATION TO 8 WEEKS OF YOGA OR USUAL CARE. BOTH GROUPS RECEIVED ONGOING MONTHLY SELF-MANAGEMENT PROGRAMMING. DATA WERE COLLECTED BEFORE AND AFTER THE 8-WEEK INTERVENTION. PARTICIPANTS WERE RANDOMIZED TO YOGA OR USUAL CARE AFTER BASELINE ASSESSMENTS. DEMOGRAPHICS WERE COLLECTED AND MEASURES INCLUDED: CANADIAN OCCUPATIONAL PERFORMANCE MEASURE (COPM) TO ASSESS OCCUPATIONAL PERFORMANCE; THE 15-ITEM FRENCHAY ACTIVITIES INDEX (FAI)(ACTIVITIES); AND THE 9-ITEM PATIENT HEALTH QUESTIONNAIRE (PHQ-9) FOR DEPRESSION. INDEPENDENT T-TESTS WERE USED TO ASSESS DIFFERENCES BETWEEN GROUPS. PAIRED T-TESTS WERE USED TO ASSESS DIFFERENCES BETWEEN PRE- AND POST 8-WEEK INTERVENTION FOR BOTH THE YOGA AND THE USUAL CARE GROUPS. PERCENT CHANGE SCORES AND EFFECT SIZES WERE CALCULATED. RESULTS: 83 PEOPLE WERE RECRUITED FOR THE STUDY AND COMPLETED BASELINE ASSESSMENTS; 44 INDIVIDUALS WERE RANDOMIZED TO YOGA AND 39 TO THE CONTROL GROUP. THE AVERAGE AGE OF ALL PARTICIPANTS WAS 51.4+/-10.5 YEARS, 68% WERE FEMALE; AND 60% HAD AT LEAST SOME COLLEGE EDUCATION. THERE WERE NO SIGNIFICANT DIFFERENCES IN DEMOGRAPHICS OR OUTCOME MEASURES BETWEEN GROUPS AT BASELINE OR 8 WEEKS; HOWEVER, THE STUDY WAS NOT POWERED TO SEE SUCH DIFFERENCES. INDIVIDUALS RANDOMIZED TO THE CONTROL GROUP DID NOT SIGNIFICANTLY IMPROVE IN ANY OUTCOME MEASURE OVER THE 8 WEEKS. THERE WERE SIGNIFICANT IMPROVEMENTS IN COPM PERFORMANCE AND COPM SATISFACTION SCORES FOR INDIVIDUALS RANDOMIZED TO THE YOGA GROUP; BOTH SCORES SIGNIFICANTLY IMPROVED. COPM PERFORMANCE IMPROVED BY 27% WITH A MODERATE TO LARGE EFFECT SIZE (3.66+/-1.85 VS 4.66+/-1.93, P < 0.001, D = 0.76). COPM SATISFACTION SIGNIFICANTLY IMPROVED BY 78% (2.14+/-2.31 VS. 3.80+/-2.50, P < 0.001) AND HAD A LARGE EFFECTS SIZE (D = 1.02). FAI SCORES IMPROVED, INDICATING INCREASED ACTIVITY OR ENGAGEMENT IN DAILY OCCUPATION DURING THE 8-WEEK INTERVENTION. SCORES INCREASED BY 5% (38.13+/-8.48 VS. 39.90+/-8.57, P = 0.024) WITH A SMALL EFFECT SIZE (D = 0.37). DEPRESSION SIGNIFICANTLY DECREASED FROM 13.21+/-5.60 TO 11.41+/-5.82, P = 0.041, WITH A SMALL EFFECT SIZE. CONCLUSION: DATA FROM THIS PILOT RCT INDICATE YOGA MAY BE AN EFFECTIVE THERAPEUTIC INTERVENTION WITH PEOPLE IN CHRONIC PAIN TO IMPROVE OCCUPATIONAL PERFORMANCE, INCREASE ENGAGEMENT IN ACTIVITIES, AND DECREASE DEPRESSION. OCCUPATIONAL THERAPY PRACTITIONERS MAY CONSIDER ADDING YOGA AS A TREATMENT INTERVENTION TO ADDRESS THE NEEDS OF PEOPLE WITH PAIN. 2019 11 1483 33 INTEGRATING YOGA WITH PSYCHOLOGICAL GROUP-TREATMENT FOR MIXED DEPRESSION AND ANXIETY IN PRIMARY HEALTHCARE: AN EXPLORATIVE PILOT STUDY. BACKGROUND AND PURPOSE: YOGA HAS SHOWN PROMISE AS A TREATMENT FOR DEPRESSION AND ANXIETY. THE PRESENT PILOT STUDY INVESTIGATED THE FEASIBILITY OF AN EIGHT-WEEK GROUPTREATMENT INTEGRATING EMOTION-FOCUSED PSYCHOEDUCATION, COMPASSION-FOCUSED THERAPY, AND VIRYA YOGA FOR DEPRESSION AND ANXIETY IN PRIMARY HEALTHCARE. MATERIALS AND METHODS: PATIENTS SEEKING TREATMENT FOR DEPRESSION AND ANXIETY IN A PRIMARY HEALTHCARE CENTRE COMPLETED EITHER AN INTEGRATIVE GROUP-TREATMENT (N = 14) OR TREATMENT AS USUAL (TAU, N = 17). OUTCOME MEASURES WERE ANALYSED PRE- AND POSTTREATMENT. CORRELATIONS IN THE INTERVENTION GROUP WERE INVESTIGATED BETWEEN TREATMENT OUTCOMES AND AMOUNT OF YOGA PRACTICE BETWEEN SESSIONS. RESULTS: LARGE WITHIN-GROUP EFFECT SIZES ON ALL OUTCOME MEASURES WERE FOUND AT POSTTREATMENT. SYMPTOM REDUCTION DID NOT DIFFER BETWEEN GROUPS (P = 0.155). IMPROVEMENT IN ALEXITHYMIA CORRELATED SIGNIFICANTLY (P < 0.05) WITH AMOUNT OF YOGA PRACTICE BETWEEN SESSIONS. CONCLUSION: INTEGRATING YOGA WITH A PSYCHOLOGICAL GROUP-TREATMENT IS A SOMEWHAT FEASIBLE APPROACH TO TREATMENT FOR DEPRESSION AND ANXIETY IN PRIMARY HEALTHCARE. 2020 12 2871 33 YOGA-BASED RELAXATION TECHNIQUE FACILITATES SUSTAINED ATTENTION IN PATIENTS WITH LOW BACK PAIN: A PILOT STUDY. CONTEXT: THE EXPERIENCE OF PAIN STRONGLY INFLUENCES SUSTAINED ATTENTION, WHICH IS IMPORTANT FOR NEUROCOGNITIVE PERFORMANCE. YOGA-BASED RELAXATION TECHNIQUES MAY BE EFFECTIVE IN IMPROVING SUSTAINED ATTENTION BY ATTENUATING PAIN IN PATIENTS WITH LOW BACK PAIN. HENCE, WE AIMED TO INVESTIGATE THE EFFECT OF A YOGA-BASED RELAXATION TECHNIQUE ON SUSTAINED ATTENTION AND SELF-REPORTED PAIN DISABILITY IN PATIENTS WITH LOW BACK PAIN. METHODS: A TOTAL OF 22 MEN AGED 30 TO 50 YEARS WITH LOW BACK PAIN WERE RECRUITED FOR THE STUDY. THEY WERE RANDOMLY ASSIGNED TO EITHER THE YOGA (N = 11) OR CONTROL (N = 11) GROUPS. THE YOGA GROUP PRACTICED A YOGA-BASED RELAXATION TECHNIQUE (YBRT) 1 HOUR A DAY FOR 4 WEEKS AND THE CONTROL GROUP MAINTAINED THEIR USUAL PHYSICAL ACTIVITY REGIMEN. ASSESSMENTS INCLUDED THE SUSTAINED ATTENTION TO RESPONSE TASK (SART) AND THE OSWESTRY LOW BACK PAIN DISABILITY QUESTIONNAIRE (OLBPDQ) MEASURED BEFORE AND AFTER THE 4-WEEK INTERVENTION. RESULTS: THE STUDY SHOWED A SIGNIFICANT REDUCTION IN ALL SELF-REPORTED OLBPDQ DOMAINS AND IMPROVEMENT IN SUSTAINED ATTENTION IN A BEFORE AND AFTER COMPARISON 4 WEEKS FOLLOWING THE YOGA INTERVENTION. PEARSON'S CORRELATION ALSO SHOWED A POSITIVE CORRELATION BETWEEN SUSTAINED ATTENTION AND PAIN REDUCTION FOLLOWING THE YOGA INTERVENTION. CONCLUSION: THE FINDINGS INDICATE THAT YOGA PRACTICE REDUCES PAIN AND SIMULTANEOUSLY IMPROVES INFORMATION PROCESSING SPEED WITH IMPULSE CONTROL DURING THE PERFORMANCE OF A SUSTAINED ATTENTION TASK. 2020 13 682 42 EFFECT OF ADJUNCT YOGA THERAPY IN DEPRESSIVE DISORDERS: FINDINGS FROM A RANDOMIZED CONTROLLED STUDY. BACKGROUND: DEPRESSION CAUSES SIGNIFICANT BURDEN BOTH TO THE INDIVIDUAL AND TO SOCIETY, AND ITS TREATMENT BY ANTIDEPRESSANTS HAS VARIOUS DISADVANTAGES. THERE IS PRELIMINARY EVIDENCE THAT ADDS ON YOGA THERAPY IMPROVES DEPRESSION BY IMPACTING THE NEUROTRANSMITTERS INVOLVED IN THE REGULATION OF MOOD, MOTIVATION, AND PLEASURE. OUR STUDY AIMED TO FIND THE EFFECT OF ADJUNCTIVE YOGA THERAPY ON OUTCOME OF DEPRESSION AND COMORBID ANXIETY. MATERIALS AND METHODS: A RANDOMIZED CONTROLLED STUDY INVOLVING PATIENTS WITH MAJOR DEPRESSIVE DISORDER (N = 80) WERE ALLOCATED TO TWO GROUPS, ONE RECEIVED STANDARD THERAPY (ANTIDEPRESSANTS AND COUNSELING) AND THE OTHER RECEIVED ADJUNCT YOGA THERAPY ALONG WITH STANDARD THERAPY. RATINGS OF DEPRESSION AND ANXIETY WERE DONE USING MONTGOMERY-ASBERG DEPRESSION RATING SCALE AND HOSPITAL ANXIETY AND DEPRESSION SCALE AT BASELINE, 10(TH) AND 30(TH) DAY. CLINICAL GLOBAL IMPRESSION (CGI) SCALE WAS APPLIED AT BASELINE AND 30(TH) DAY TO VIEW THE SEVERITY OF ILLNESS AND CLINICAL IMPROVEMENT. RESULTS: BY THE 30(TH) DAY, INDIVIDUALS IN THE YOGA GROUP HAD SIGNIFICANTLY LOWER SCORES OF DEPRESSION, ANXIETY, AND CGI SCORES, IN COMPARISON TO THE CONTROL GROUP. THE INDIVIDUALS IN THE YOGA GROUP HAD A SIGNIFICANT FALL IN DEPRESSION SCORES AND SIGNIFICANT CLINICAL IMPROVEMENT, COMPARED TO THE CONTROL GROUP, FROM BASELINE TO 30(TH) DAY AND 10(TH) TO 30(TH) DAY. IN ADDITION, THE INDIVIDUALS IN THE YOGA GROUP HAD A SIGNIFICANT FALL IN ANXIETY SCORES FROM BASELINE TO 10(TH) DAY. CONCLUSION: ANXIETY STARTS TO IMPROVE WITH SHORT-TERM YOGA SESSIONS, WHILE LONG-TERM YOGA THERAPY IS LIKELY TO BE BENEFICIAL IN THE TREATMENT OF DEPRESSION. 2019 14 2187 52 THE EFFECTS OF YOGA ON STUDENT MENTAL HEALTH: A RANDOMISED CONTROLLED TRIAL. BACKGROUND: UNIVERSITIES AROUND THE WORLD ARE FACING AN EPIDEMIC OF MENTAL DISTRESS AMONG THEIR STUDENTS. THE PROBLEM IS TRULY A PUBLIC HEALTH ISSUE, AFFECTING MANY AND WITH SERIOUS CONSEQUENCES. THE GLOBAL BURDEN OF DISEASE-AGENDA CALLS FOR EFFECTIVE INTERVENTIONS WITH LASTING EFFECTS THAT HAVE THE POTENTIAL TO IMPROVE THE MENTAL HEALTH OF YOUNG ADULTS. IN THIS STUDY WE AIMED TO DETERMINE WHETHER YOGA, A POPULAR AND WIDELY AVAILABLE MIND-BODY PRACTICE, CAN IMPROVE STUDENT MENTAL HEALTH. METHODS: WE PERFORMED A RANDOMISED CONTROLLED TRIAL WITH 202 HEALTHY UNIVERSITY STUDENTS IN THE OSLO AREA. THE PARTICIPANTS WERE ASSIGNED TO A YOGA GROUP OR WAITLIST CONTROL GROUP IN A 1:1 RATIO BY A SIMPLE ONLINE RANDOMISATION PROGRAM. THE INTERVENTION GROUP WAS OFFERED 24 YOGA SESSIONS OVER 12 WEEKS. MEASUREMENTS WERE TAKEN AT WEEK 0 (BASELINE), WEEK 12 (POST-INTERVENTION), AND WEEK 24 (FOLLOW-UP). THE PRIMARY OUTCOME WAS PSYCHOLOGICAL DISTRESS ASSESSED BY THE HSCL-25 QUESTIONNAIRE. ANALYSIS WAS PERFORMED BASED ON THE INTENTION TO TREAT-PRINCIPLE. RESULTS: BETWEEN 24 JANUARY 2017, AND 27 AUGUST 2017, WE RANDOMLY ASSIGNED 202 STUDENTS TO A YOGA INTERVENTION GROUP (N = 100), OR WAITLIST CONTROL GROUP (N = 102). COMPARED WITH THE CONTROL GROUP, THE YOGA PARTICIPANTS DEMONSTRATED A SIGNIFICANT REDUCTION IN DISTRESS SYMPTOMS BOTH AT POST-INTERVENTION (ADJUSTED DIFFERENCE IN THE MEAN CHANGE -0.15, 95% CI -0.26 TO -0.03, P = 0.0110) AND FOLLOW-UP (ADJUSTED DIFFERENCE IN THE MEAN CHANGE -0.18, 95% CI -0.29 TO -0.06, P = 0.0025). SLEEP QUALITY ALSO IMPROVED AT POST-INTERVENTION AND FOLLOW-UP. NO ADVERSE EVENTS WERE REPORTED. CONCLUSIONS: OUR FINDINGS SUGGEST THAT YOGA HAS A MODERATELY LARGE AND LASTING EFFECT, AT LEAST FOR SOME MONTHS, REDUCING SYMPTOMS OF DISTRESS AND IMPROVING SLEEP QUALITY AMONG STUDENTS. FURTHER RESEARCH SHOULD SEEK WAYS TO ENHANCE THE EFFECT, ASSESS AN EVEN LONGER FOLLOW-UP PERIOD, INCLUDE ACTIVE CONTROL GROUPS, AND CONSIDER PERFORMING SIMILAR STUDIES IN OTHER CULTURAL SETTINGS.TRIAL REGISTRATION: CLINICALTRIALS.GOV IDENTIFIER: NCT04258540. 2020 15 2687 23 YOGA IN THE TREATMENT OF EATING DISORDERS WITHIN A RESIDENTIAL PROGRAM: A RANDOMIZED CONTROLLED TRIAL. TO INVESTIGATE THE EFFECT OF YOGA ON NEGATIVE AFFECT (AN EATING DISORDERS RISK FACTOR), 38 INDIVIDUALS IN A RESIDENTIAL EATING DISORDER TREATMENT PROGRAM WERE RANDOMIZED TO A CONTROL OR YOGA INTERVENTION: 1 HOUR OF YOGA BEFORE DINNER FOR 5 DAYS. NEGATIVE AFFECT WAS ASSESSED PRE- AND POST-MEAL. MIXED-EFFECTS MODELS COMPARED NEGATIVE AFFECT BETWEEN GROUPS DURING THE INTERVENTION PERIOD. YOGA SIGNIFICANTLY REDUCED PRE-MEAL NEGATIVE AFFECT COMPARED TO TREATMENT AS USUAL; HOWEVER, THE EFFECT WAS ATTENUATED POST-MEAL. MANY EATING DISORDERS PROGRAMS INCORPORATE YOGA INTO TREATMENT. THIS PRELIMINARY EVIDENCE SETS THE STAGE FOR LARGER STUDIES EXAMINING YOGA AND EATING DISORDER TREATMENT AND PREVENTION. 2017 16 2112 30 THE EFFECT OF YOGA ON STRESS, ANXIETY, AND DEPRESSION IN WOMEN. BACKGROUND: IN RECENT DECADES, SEVERAL MEDICAL AND SCIENTIFIC STUDIES ON YOGA PROVED IT TO BE VERY USEFUL IN THE TREATMENT OF SOME DISEASES. THIS STUDY WAS CONDUCTED TO INVESTIGATE THE EFFECTS OF YOGA ON STRESS, ANXIETY, AND DEPRESSION IN WOMEN LIVING IN ILAM, IRAN. METHODS: THIS STUDY IS A QUASI-EXPERIMENTAL STUDY WITH PRE-POST TEST. TO COLLECT DATA, THE QUESTIONNAIRE OF DASS-21 (DEPRESSION ANXIETY STRESS SCALE-21) WAS USED. FOR ELIGIBLE SAMPLES, HATHA YOGA EXERCISES AND TRAINING SESSIONS WERE HELD FOR 4 WEEKS (3 TIME/WEEKS; 60-70 MIN EACH) BY A SPECIALIST. DATA WERE ANALYZED USING SPSS VERSION 20. RESULTS: 52 WOMEN WITH A MEAN AGE OF 33.5 +/- 6.5 WERE INCLUDED FOR ANALYSIS. DEPRESSION, ANXIETY, AND STRESS DECREASED SIGNIFICANTLY IN WOMEN AFTER 12 SESSIONS OF REGULAR HATHA YOGA PRACTICE (P < 0.001). CONCLUSIONS: YOGA HAS AN EFFECTIVE ROLE IN REDUCING STRESS, ANXIETY, AND DEPRESSION. THUS, IT CAN BE USED AS COMPLEMENTARY MEDICINE. 2018 17 293 45 AEROBIC EXERCISE AND YOGA IMPROVE NEUROCOGNITIVE FUNCTION IN WOMEN WITH EARLY PSYCHOSIS. IMPAIRMENTS OF ATTENTION AND MEMORY ARE EVIDENT IN EARLY PSYCHOSIS, AND ARE ASSOCIATED WITH FUNCTIONAL DISABILITY. IN A GROUP OF STABLE, MEDICATED WOMEN PATIENTS, WE AIMED TO DETERMINE WHETHER PARTICIPATING IN AEROBIC EXERCISE OR YOGA IMPROVED COGNITIVE IMPAIRMENTS AND CLINICAL SYMPTOMS. A TOTAL OF 140 FEMALE PATIENTS WERE RECRUITED, AND 124 RECEIVED THE ALLOCATED INTERVENTION IN A RANDOMIZED CONTROLLED STUDY OF 12 WEEKS OF YOGA OR AEROBIC EXERCISE COMPARED WITH A WAITLIST GROUP. THE PRIMARY OUTCOMES WERE COGNITIVE FUNCTIONS INCLUDING MEMORY AND ATTENTION. SECONDARY OUTCOME MEASURES WERE THE SEVERITY OF PSYCHOTIC AND DEPRESSIVE SYMPTOMS, AND HIPPOCAMPAL VOLUME. DATA FROM 124 PATIENTS WERE INCLUDED IN THE FINAL ANALYSIS BASED ON THE INTENTION-TO-TREAT PRINCIPLE. BOTH YOGA AND AEROBIC EXERCISE GROUPS DEMONSTRATED SIGNIFICANT IMPROVEMENTS IN WORKING MEMORY (P<0.01) WITH MODERATE TO LARGE EFFECT SIZES COMPARED WITH THE WAITLIST CONTROL GROUP. THE YOGA GROUP SHOWED ADDITIONAL BENEFITS IN VERBAL ACQUISITION (P<0.01) AND ATTENTION (P=0.01). BOTH TYPES OF EXERCISE IMPROVED OVERALL AND DEPRESSIVE SYMPTOMS (ALL P0.01) AFTER 12 WEEKS. SMALL INCREASES IN HIPPOCAMPAL VOLUME WERE OBSERVED IN THE AEROBIC EXERCISE GROUP COMPARED WITH WAITLIST (P=0.01). BOTH TYPES OF EXERCISE IMPROVED WORKING MEMORY IN EARLY PSYCHOSIS PATIENTS, WITH YOGA HAVING A LARGER EFFECT ON VERBAL ACQUISITION AND ATTENTION THAN AEROBIC EXERCISE. THE APPLICATION OF YOGA AND AEROBIC EXERCISE AS ADJUNCTIVE TREATMENTS FOR EARLY PSYCHOSIS MERITS SERIOUS CONSIDERATION. THIS STUDY WAS SUPPORTED BY THE SMALL RESEARCH FUNDING OF THE UNIVERSITY OF HONG KONG (201007176229), AND RGC FUNDING (C00240/762412) BY THE AUTHORITY OF RESEARCH, HONG KONG. 2015 18 1267 38 FOLLOW-UP OF YOGA OF AWARENESS FOR FIBROMYALGIA: RESULTS AT 3 MONTHS AND REPLICATION IN THE WAIT-LIST GROUP. OBJECTIVES: PUBLISHED PRELIMINARY FINDINGS FROM A RANDOMIZED-CONTROLLED TRIAL SUGGEST THAT AN 8-WEEK YOGA OF AWARENESS INTERVENTION MAY BE EFFECTIVE FOR IMPROVING SYMPTOMS, FUNCTIONAL DEFICITS, AND COPING ABILITIES IN FIBROMYALGIA. THE PRIMARY AIMS OF THIS STUDY WERE TO EVALUATE THE SAME INTERVENTION'S POSTTREATMENT EFFECTS IN A WAIT-LIST GROUP AND TO TEST THE INTERVENTION'S EFFECTS AT 3-MONTH FOLLOW-UP IN THE IMMEDIATE TREATMENT GROUP. METHODS: UNPAIRED T TESTS WERE USED TO COMPARE DATA FROM A PER PROTOCOL SAMPLE OF 21 WOMEN IN THE IMMEDIATE TREATMENT GROUP WHO HAD COMPLETED TREATMENT AND 18 WOMEN IN THE WAIT-LIST GROUP WHO HAD COMPLETED TREATMENT. WITHIN-GROUP PAIRED T TESTS WERE PERFORMED TO COMPARE POSTTREATMENT DATA WITH 3-MONTH FOLLOW-UP DATA IN THE IMMEDIATE TREATMENT GROUP. THE PRIMARY OUTCOME MEASURE WAS THE FIBROMYALGIA IMPACT QUESTIONNAIRE REVISED (FIQR). MULTILEVEL RANDOM-EFFECTS MODELS WERE ALSO USED TO EXAMINE ASSOCIATIONS BETWEEN YOGA PRACTICE RATES AND OUTCOMES. RESULTS: POSTTREATMENT RESULTS IN THE WAIT-LIST GROUP LARGELY MIRRORED RESULTS SEEN AT POSTTREATMENT IN THE IMMEDIATE TREATMENT GROUP, WITH THE FIQR TOTAL SCORE IMPROVING BY 31.9% ACROSS THE 2 GROUPS. FOLLOW-UP RESULTS SHOWED THAT PATIENTS SUSTAINED MOST OF THEIR POSTTREATMENT GAINS, WITH THE FIQR TOTAL SCORE REMAINING 21.9% IMPROVED AT 3 MONTHS. YOGA PRACTICE RATES WERE GOOD, AND MORE PRACTICE WAS ASSOCIATED WITH MORE BENEFIT FOR A VARIETY OF OUTCOMES. DISCUSSION: THESE FINDINGS INDICATE THAT THE BENEFITS OF YOGA OF AWARENESS IN FIBROMYALGIA ARE REPLICABLE AND CAN BE MAINTAINED. 2012 19 2461 39 YOGA AS A NOVEL ADJUVANT THERAPY FOR PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES. CONTEXT: RECENT STUDIES HAVE DEMONSTRATED THAT PHYSICAL ACTIVITY IS WELL TOLERATED BY PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) AND CAN HAVE ADDITIONAL BENEFITS AS AN ADJUVANT THERAPY TO PHARMACOLOGIC AGENTS, ESPECIALLY IF STARTED EARLY. TO DATE, NO STUDIES HAVE EXAMINED THE EFFECTS OF YOGA ON PATIENTS WITH IIMS. AIMS: THE AIM OF THIS STUDY WAS TO EVALUATE THE EFFECTS OF YOGA ON SELF-REPORTED DIFFICULTY IN PERFORMING ACTIVITIES OF DAILY LIVING (ADL) AND MUSCLE STRENGTH IN PATIENTS WITH MILD-TO-MODERATE IIMS. SUBJECTS AND METHODS: A LONGITUDINAL COHORT STUDY IN WHICH PARTICIPANTS WERE ASSESSED USING THE MYOSITIS ACTIVITIES PROFILE (MAP) AND MANUAL MUSCLE TESTING (MMT) BEFORE AND AFTER THE COMPLETION OF AN 8-WEEK INSTRUCTOR-GUIDED YOGA COURSE WAS PERFORMED. STATISTICAL ANALYSIS USED: WILCOXON SIGNED-RANKED TEST WAS PERFORMED FOR STATISTICAL ANALYSIS. RESULTS: THE AVERAGE POSTTREATMENT MAP SCORES OF SIX PARTICIPANTS DEMONSTRATED AN INCREASE OF 2.51 POINTS, WHILE THE AVERAGE MMT SCORE OF FOUR PARTICIPANTS DEMONSTRATED AN INCREASE OF 11 POINTS. CONCLUSIONS: THIS STUDY IS THE FIRST STUDY TO DATE TO EXAMINE THE EFFECT OF YOGA AS AN ADJUVANT COMPLEMENTARY THERAPY FOR PATIENTS WITH IIM. CONTINUED RESEARCH SHOULD BE DONE ON THE EFFECT OF YOGA AS AN ADJUVANT THERAPY, FOR IN ADDITION TO INCREASE IN MUSCLE STRENGTH AND ABILITY TO PERFORM ADL, YOGA MAY OFFER POTENTIAL IMPROVEMENTS IN MOOD, MENTAL HEALTH, AND SLEEP. 2021 20 270 49 ADD ON YOGA TREATMENT FOR NEGATIVE SYMPTOMS OF SCHIZOPHRENIA: A MULTI-CENTRIC, RANDOMIZED CONTROLLED TRIAL. THE EFFICACY OF ANTIPSYCHOTIC MEDICATIONS IN THE TREATMENT OF NEGATIVE SYMPTOMS OF SCHIZOPHRENIA IS MODEST AT BEST. PRELIMINARY STUDIES SUGGEST THE BENEFICIAL EFFECTS OF ADD ON YOGA, A TRADITIONAL INDIAN PRACTICE, IN THE TREATMENT OF SCHIZOPHRENIA. HENCE, IN THIS STUDY, WE EXAMINED THE EFFICACY OF YOGA AS AN ADD-ON TREATMENT FOR NEGATIVE SYMPTOMS OF SCHIZOPHRENIA IN A RANDOMIZED, WAIT-LIST CONTROLLED DESIGN FROM TWO CLINICAL INSTITUTES IN SOUTH INDIA. 89 PATIENTS (AGE - 34.20 +/- 8.06 YEARS; EDUCATION - 14.22 +/- 2.69 YEARS; 28 FEMALES) WERE RANDOMIZED INTO THE ADD-ON YOGA OR TREATMENT AS USUAL (TAU - WAIT-LIST CONTROL) GROUP. PATIENTS HAD A MEAN ILLNESS DURATION OF 10.97 +/- 7.24 YEARS WITH AN AGE AT ONSET OF 23.34 +/- 5.81 YEARS. CENTRAL BLOCK RANDOMIZATION WAS FOLLOWED TO ENSURE CONCEALED ALLOCATION. PARTICIPANTS RANDOMIZED TO THE YOGA TREATMENT GROUP ATTENDED 12 SUPERVISED YOGA TRAINING SESSIONS OVER TWO WEEKS AND PRACTICED YOGA SESSIONS AT HOME FOR THE SUBSEQUENT 10 WEEKS. 64 PATIENTS COMPLETED THE TRIAL. AN INTENT TO TREAT ANALYSIS WAS CONDUCTED WITH 89 PARTICIPANTS USING A LINEAR MIXED MODEL. IMPROVEMENT IN NEGATIVE SYMPTOMS WAS OUR PRIMARY OUTCOME MEASURE. THE TWO GROUPS WERE MATCHED ON DEMOGRAPHIC VARIABLES AND BASELINE PSYCHOPATHOLOGY SEVERITY. PARTICIPANTS IN THE ADD-ON YOGA GROUP HAD SIGNIFICANTLY GREATER IMPROVEMENT IN NEGATIVE SYMPTOMS (SANS BASELINE: 49.13 +/- 2.30; 12-WEEKS FOLLOW UP: 31.55 +/- 2.53) COMPARED TO THE TAU GROUP (SANS BASELINE: 51.22 +/- 2.40; 12-WEEKS FOLLOW UP: 45.30 +/- 2.93; T = 3.36; P = 0.006; COHEN'S D-0.65). THE CURRENT STUDY FINDINGS SUGGEST THE EFFICACY OF YOGA AS AN ADD-ON TREATMENT FOR NEGATIVE SYMPTOMS OF SCHIZOPHRENIA. THE EFFECTIVENESS OF YOGA PRACTICE AS A REGULAR CLINICAL INTERVENTION FOR PATIENTS NEEDS TO BE EXPLORED IN FUTURE STUDIES BY INTEGRATING YOGA SERVICES ALONG WITH OTHER CLINICAL SERVICES. 2021